首页 > 市场调查报告书 > 食物/饮料

保健食品

市场调查报告书

商品编码

1588572

全球食品药品市场 - 2024-2031

Global Food as a Medicine Market - 2024-2031

出版日期: 2024年11月08日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023 年，全球食品药品市场规模达到 47.1 亿美元，预计到 2031 年将达到 115.1 亿美元，2024-2031 年预测期间复合年增长率为 12.2%。

食物作为药物是指在个人的健康计画中优先考虑食物和饮食，以预防、减少或预防疾病症状。「食物作为药物」的健康管理方法挑战了传统医学的基础，传统医学主要依赖医学技术的发展来使用药物来治疗健康和疾病。使用「食物作为药物」可以透过改善实验室工作、减少药物和减少住院来降低疾病的严重程度，从而降低医疗费用。

许多受过教育和知识渊博的消费者更喜欢将食品作为一种药物方法，而不是包括药物和其他治疗方法的药物治疗。例如，根据食品安全网路服务 (FSNS) 2023 年 5 月的一项研究，55% 的顾客愿意支付溢价购买可以作为药物、改善他们的健康和福祉的食品。

市场动态：

驱动程式和限制

慢性病盛行率上升

慢性病盛行率的增加极大地推动了食品药品市场的成长，预计将在整个市场预测期内推动成长。随着人们的健康意识越来越强，他们正在积极寻找预防疾病、增强免疫力、控制持续疾病以及透过食物治疗来改善整体健康的方法。因此，食品越来越被视为实现这些健康目标的关键组成部分。

各种饮食策略，例如抗发炎食品、心血管替代品、抗衰老营养和排毒饮食，作为补充疗法和现代医疗程序的重要组成部分越来越受欢迎。这种日益增强的意识正在使人们转向以食物为中心的解决方案，随着人们寻求自然、可持续和有效的方法来管理和避免慢性病，预计这种意识将继续下去。传统的治疗食品因其性质且无副作用而受到越来越多的需求。

例如，根据美国国立卫生研究院2024年的数据，到2030年，糖尿病盛行率预计将达到6.43亿，这主要是由于发展中国家的糖尿病盛行率增加了150%。印度、中国、美国、印尼、日本、巴基斯坦、俄罗斯、巴西、义大利和孟加拉是糖尿病发生率最高的国家。糖尿病已被确定为全球严重的健康问题。低收入和中等收入国家的糖尿病病例成长速度远快于高收入国家。

随着癌症盛行率的不断增加，人们越来越关注食品作为一种疾病预防方法，以降低健康风险，并将食品作为药物。食物和癌症预防之间的关係变得越来越简单，一些食物被认为具有潜在的抗癌作用。随着世界各地癌症数量的增加，人们正在转向可以帮助最大限度地减少疾病恶化机会的食物。由于心血管疾病是全球死亡的首要原因之一，透过食物支持心血管已成为食药市场的重要组成部分。

人们对食物作为药物的认识有限

对食品作为药物方法的认识有限预计将阻碍食品作为药物市场的成长。很大一部分人没有意识到可持续生产的食品对健康和环境的好处，这些食品可以预防和治疗多种疾病。由于缺乏意识，生产商无法吸引那些可能对更健康、有机或环保产品感兴趣的个人。在没有充分了解其好处的情况下，客户会选择他们认为比食品更熟悉且更实惠的传统食品作为药物。

Food as a medicine refers to prioritizing food and diet in an individual's health plan to prevent, reduce, or prevent disease symptoms. The "food as a medicine" approach to health management challenges the foundation of conventional medicine, which depends primarily on technological medical developments to treat health and disease using pharmaceutical medications. Using "food as a medicine" may lower healthcare expenses by potentially reducing illness severity through improved labwork, fewer drugs, and fewer hospitalizations.

A large number of educated and knowledged consumers prefer food as a medicine approach over medications which includes drugs and other treatments. For instance, according to a study by the Food Safety Net Services (FSNS) in May 2023, 55% of customers are willing to pay a premium for food that can act as medicine, improving their health and well-being.

Market Dynamics: Drivers & Restraints

Rising prevalence of chronic diseases

The increasing prevalence of chronic diseases is significantly driving the growth of the food as a medicine market and is expected to drive throughout the market forecast period. As people are becoming more health conscious, they are actively looking for ways to prevent illnesses, increase immunity, manage ongoing illness, and improve their general well-being by adopting food as a medicine approach. As a result, food is increasingly regarded as a critical component in accomplishing these health goals.

Various dietary strategies, such as anti-inflammatory foods, cardiovascular alternatives, anti-aging nutrition, and detoxifying diets are gaining popularity as supplementary therapies and as essential components of modern healthcare procedures. This increasing awareness is shifting individuals toward food-centric solutions and is expected to continue as people seek natural, sustainable, and effective ways to manage and avoid chronic conditions. Traditional healing foods are gaining demand due to their nature and with no side effects.

For instance, according to the National Institute of Health in 2024, the prevalence of diabetes is expected to reach 643 million by 2030, which is mainly due to a 150% increase in developing nations. India, China, the United States, Indonesia, Japan, Pakistan, Russia, Brazil, Italy, and Bangladesh are the countries with the highest diabetes rates. Diabetes has been identified as a serious worldwide health concern. Diabetes cases are growing at a far faster rate in low- and middle-income countries than in high-income countries.

With the increasing prevalence of cancer, there is an increasing focus on food as a disease prevention approach to reduce health risks and use food as a medicine. The relationship between food and cancer prevention is becoming simpler, with several foods being identified as having potential anti-cancer effects. As the number of cancers increases around the world, people are turning to food that can help minimize their chance of worsening the disease. With cardiovascular disease as one of the top causes of mortality worldwide, cardiovascular support through food has become an important component of the food as medicine market.

Limited awareness among individuals about food as a medicine

Limited awareness of food as a medicine approach is expected to hinder food as a medicine market growth. A large proportion of people are unaware of the health and environmental benefits of sustainably produced foods which prevent and cure a large number of illnesses. Because of this lack of awareness, producers fail to attract individuals who may otherwise be interested in healthier, organic, or environmentally friendly products. Without an adequate understanding of the benefits, customers choose conventional food products that they believe to be more familiar and affordable over food as a medicine approach.

Segment Analysis

The global food as a medicine market is segmented based on product type, form, application, distribution channel and region.

Medical Foods segment is expected to dominate the food as a medicine market share

The medical foods segment holds a major portion of the food as a medicine market share and is expected to continue to hold a significant portion of the food as a medicine market share during the forecast period. Medical foods differ from the broader category of foods for special dietary use in that they are intended to meet the unique nutritional requirements of a disease or condition, must be used under medical supervision, and are intended for the specific dietary management of a disease or condition.

The segment is expected to dominate the food as a medicine market share due to the increasing awareness among individuals about nutritional therapies rather than completely depending on drugs to cure the disease. A wide range of medical foods with different compositions and various applications are being introduced by the food as a medicine market players which are contributing to the segment expansion.

A large number of key players are adopting strategies to increase production capacity and expand their businesses which is expected to drive the segment's expansion. With these strategies, companies are expanding their portfolios and penetrating other regions, which is driving the segment's growth and is expected to hold the major share in the food as medicine market.

For instance, in September 2024, Dutch Medical Food B.V. made its official entry into the Indian market via a strategic relationship with Pristine Pearl Pharma Pvt. Ltd. This collaboration represents the introduction of an innovative line of products to treat disease-related malnutrition in both adult and pediatric populations. The latest offerings are primarily targeted at illnesses such as cancer, pediatric malnutrition, COPD, and drug-resistant epilepsy, to considerably improve health outcomes across India.

Similarly, in August 2024, Avesthagen Ltd and Apollo AyurVAID formed a strategic partnership to manufacture and market medical foods and dietary supplements. Following the collaboration, Avesthagen Ltd and Apollo AyurVAID will combine their skills and knowledge to design, manufacture, and market precision medical foods based on new tactics that improve patient care and promote holistic well-being.

Geographical Analysis

North America is expected to hold a significant position in the food as a medicine market share

North America holds a substantial position in the food as medicine market and is expected to hold most of the market share. This is due to the growing demand for foods and diet over medicine in the region with the increasing awareness among individuals. The increasing number of chronic diseases in the region is raising the demand for food-based therapies. There is a rising approach to food as a medicine that can be personalized.

The government bodies in the region are hosting summits and taking initiatives to increase awareness among individuals on food as medicine approaches. For instance, on January 31, 2024, the U.S. Department of Health and Human Services (HHS) hosted its first-ever Food is Medicine Summit in Washington, D.C., an all-day summit for stakeholders at the intersection between food and health. Secretary Xavier Becerra opened the summit by announcing three new public-private partnerships with Instacart, the Rockefeller Foundation, and Feeding America. All three partnerships will support HHS's nutrition goals.

Additionally, market players in the region are introducing advanced products of food as medicine and they are introducing new platforms to make the products available for all the individuals seeking these food-based treatments. These market players are expanding their businesses by adopting various strategies such as partnerships with each other and launching new products to make them meet the rising demand.

For instance, on August 26, 2024, Good Measures and Point32Health partnered to offer personalized nutrition support to members of Harvard Pilgrim Health Care, one of Point32Health's two insurance subsidiaries. The initiative provides nutrition counseling, food tracking, and other services through the Good Measures app, targeting conditions such as diabetes, heart disease, and obesity.

Similarly, on 16 Jul 2024, Season Health partnered with Mealogic at launch to deliver nutritionally tailored, culturally diverse meals to their patients. Mealogic has consistently provided low-cost, high-quality meals that have driven program adoption and delivered measurable clinical results nationwide.

There is an increasing shift and trend towards self-care through nutrition-based foods in the region which is also expected to contribute to the region's food as a medicine market share. Thus, with various strategies by the market players, increasing initiatives by the government bodies and the increasing incidence of chronic diseases, the food as a medicine market is expected to grow and the region is expected to dominate the global food as a medicine market share.

Market Segmentation

By Product Type

Dietary Supplements
Functional Foods and Beverages
Medical Foods
Whole Foods and Natural Foods

By Form

Capsules
Tablets
Powders
Liquid
Bars

By Application

Cardiovascular
Anti-Aging
Detoxification
Nutritional Deficiency
Diabetes
Anti-Cancer
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Supermarkets

By Region

North America
- The U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Middle East and Africa

Competitive Landscape

The major global players in the food as a medicine market include Bionova, Nestle, Primus Pharmaceuticals, Inc., Season Health, Mead Johnson & Company, LLC., SFI Health, Metagenics, Meiji Holdings Co., Ltd., Bitewell and Mealogic among others.

Key Developments

In April 2024, Vevolution, an Agrifoodtech investment platform, announced that it will organize a virtual pitch event themed "Food as Medicine". The sector is quickly gaining investment interest and encompasses areas like personalized nutrition, functional ingredients, sugar and salt alternatives, and microbiome health.
In March 2023, Instacart Health introduced tools for scaling 'Food as Medicine' programs. Healthcare professionals can now use Instacart's suite of digital technologies to improve collaborative care, promote healthy choices, and provide nutritious food to patients and their families, especially those who live in food deserts or require a medically restricted diet.

Why Purchase the Report?

To visualize the global food as a medicine market segmentation based on product type, form, application, distribution channel, and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of food as a medicine market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global food as a medicine market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Form
3.3. Snippet by Application
3.4. Snippet by Distribution Channel
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising prevalence of chronic diseases
- 4.1.2. Restraints
  - 4.1.2.1. Limited awareness among individuals about food as a medicine
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Dietary Supplements*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Functional Foods and Beverages
6.4. Medical Foods
6.5. Whole Foods and Natural Foods

7. By Form

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 7.1.2. Market Attractiveness Index, By Form
7.2. Capsules*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Tablets
7.4. Powders
7.5. Liquid
7.6. Bars

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Cardiovascular*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Anti-Aging
8.4. Detoxification
8.5. Nutritional Deficiency
8.6. Diabetes
8.7. Anti-Cancer
8.8. Others

9. By Distribution Channel

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.1.2. Market Attractiveness Index, By Distribution Channel
9.2. Hospital Pharmacies*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Retail Pharmacies
9.4. Online Pharmacies
9.5. Drug Stores
9.6. Supermarkets

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
  - 10.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  - 10.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  - 10.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  - 10.2.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.3.1. The U.S.
  - 10.2.3.2. Canada
  - 10.2.3.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
  - 10.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  - 10.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  - 10.3.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.4.1. Germany
  - 10.3.4.2. UK
  - 10.3.4.3. France
  - 10.3.4.4. Italy
  - 10.3.4.5. Spain
  - 10.3.4.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
  - 10.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  - 10.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  - 10.4.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.4.1. Brazil
  - 10.4.4.2. Argentina
  - 10.4.4.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
  - 10.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  - 10.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  - 10.5.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.4.1. China
  - 10.5.4.2. India
  - 10.5.4.3. Japan
  - 10.5.4.4. South Korea
  - 10.5.4.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
  - 10.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  - 10.6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  - 10.6.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Bionova*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Nestle
12.3. Primus Pharmaceuticals, Inc.
12.4. Season Health
12.5. Mead Johnson & Company, LLC.
12.6. SFI Health
12.7. Metagenics
12.8. Meiji Holdings Co., Ltd.
12.9. Bitewell
12.10. Mealogic

LIST NOT EXHAUSTIVE

13. Appendix

13.1. About Us and Services
13.2. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球食品药品市场 - 2024-2031

Global Food as a Medicine Market - 2024-2031

市场动态：

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

第 5 章：产业分析

第 6 章：依产品类型

第 7 章：按形式

第 8 章：按申请

第 9 章：按配销通路

第 10 章：按地区

第 11 章：竞争格局

第 12 章：公司简介

第 13 章：附录